Skip to main content
Article thumbnail
Location of Repository

Characterisation of physico-mechanical properties and degradation potential of calcium alginate beads for use in embolisation

By R.E.J. Forster, F. Thurmer, C. Wallrapp, Andrew Lloyd, Wendy Macfarlane, Gary Phillips, J.-P. Boutrand and A.L. Lewis


High molecular weight alginate beads with 59% mannuronic acid content or 68% guluronic acid were prepared using a droplet generator and crosslinked in calcium chloride. The alginate beads were compared to current embolisation microspheres for compressibility and monitored over 12 weeks for size and weight change at 37 degrees C in low volumes of ringers solutions. A sheep uterine model was used to analyse bead degradation and inflammatory response over 12 weeks. Both the in vitro and in vivo data show good delivery, with a compressibility similar to current embolic beads. In vitro, swelling was noted almost immediately and after 12 weeks the first signs of degradation were noted. No difference was noted in vivo. This study has shown that high molecular weight alginate gel beads were well tolerated by the body, but beads associated with induced thrombi were susceptible to inflammatory cell infiltration. The beads were shown to be easy to handle and were still observable after 3 months in vivo. The beads were robust enough to be delivered through a 2.7 Fr microcatheter. This study has demonstrated that high molecular weight, high purity alginate bead can be considered as semi-permanent embolisation beads, with the potential to bioresorb over time

Topics: C000 Biological and Biomedical Sciences
Publisher: Springer
Year: 2010
DOI identifier: 10.1007/s10856-010-4080-y
OAI identifier:

Suggested articles


  1. A versatile alginate droplet generator applicable for microencapsulation of pancreatic islets. doi
  2. Acrylamido polyvinyl alcohol microspheres for uterine artery embolization: 12-month clinical and MR imaging results. doi
  3. (1997). Alginate based new materials. doi
  4. Arterial embolisation to treat uterine myomata. doi
  5. (2010). Biocompatibility of microcapsules for cell immobilization elaborated with different type of alginates. doi
  6. Calcium alginate gel: a biocompatible and mechanically stable polymer for endovascular embolization. doi
  7. Cerebral transplantation of encapsulated mesenchymal stem cells improves cellular pathology after experimental traumatic brain injury. doi
  8. (1996). Chemistry and physical properties of alginates. Carbohydr Eur.
  9. Comparative in vitro evaluation of microspherical embolisation agents. doi
  10. (2010). Diagnosis and management of uterine fibroids.
  11. Effect of Ca2?-alginate gel dissolution on release of dextran with different molecular weights. doi
  12. (1990). Effects of sterilization treatments on some properties of alginate solutions and gels. Biotechnol Prog. doi
  13. (2009). Experimental liver embolization with four different spherical embolic materials: impact on inflammatory tissue and foreign body reaction. Cardiovasc Interv Radiol. doi
  14. GLP-1 CellBeads enhance myocardial angiogenesis and improve LV function. Eur Heart J. 2009;30(Abstract Supplement):495.
  15. Immunohistochemical characterization of specific inflammatory tissue reactions following embolization with four different spherical agents in the minipig kidney model. doi
  16. Location of vessel occlusion of calibrated trisacryl gelatin microspheres for tumor and arteriovenous malformation embolization. doi
  17. (2008). Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Interv Radiol. doi
  18. Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. doi
  19. (2004). Opinion. Uterine artery embolization. Obstet Gynecol. doi
  20. (1955). Polyuronic acids in brown algae. Hoppe Seylers Z Physiol Chem.
  21. Regulating bone formation via controlled scaffold degradation. doi
  22. (1996). Review: hydrogels for cell immobilization. Biotechnol Bioeng. doi
  23. (1963). The degradation of alginates at different pH values. Acta Chem Scand. doi
  24. (1965). The effect of divalent metals on the properties of alginate solutions. II. Comparison of different metal ions. Acta Chem Scand. doi
  25. (2005). The Fibroid Registry for outcomes data (FIBROID) for uterine embolization: short-term outcomes. Obstet Gynecol. doi
  26. Transcatheter embolization of pelvic vessels for control of intractable hemorrhage. doi
  27. Uterine artery embolization in sheep: comparison of acute effects with polyvinyl alcohol particles and calibrated microspheres. doi
  28. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years’ outcome from the randomized EMMY trial. doi
  29. Uterine fibroids: uterine artery embolization versus abdominal hysterectomy for treatment—a prospective, randomized, and controlled clinical trial. doi
  30. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. doi
  31. (2006). Vascular embolotherapy: a comprehensive approach. Medical radiology, 0942-5373. Diagnostic imaging. doi
  32. Verfahren Zur Gewinnung Hochgereinigter Alginate. In:

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.